Can Levosimendan Be a Treatment Option in Subarachnoid Hemorrhage?
Journal Title: Türk Yoğun Bakım Dergisi - Year 2018, Vol 16, Issue 2
Abstract
Despite improvements in medical and surgical treatment, aneurysmatic subarachnoid hemorrhage (SAH) remains one of the main causes of early mortality. Cardiac and pulmonary complications are the main causes of mortality. One of the most severe cardiac complications is neurogenic stress cardiomyopathy. Left ventricular dysfunction which is seen in neurogenic stress cardiomyopathy, although it is usually reversible within a few days, can cause severe hypotension, pulmonary edema and cardiogenic shock. Traditional treatment of heart failure after SAH is based on the use of noradrenaline, dobutamine and high volume of fluids. However, it is difficult to treat reduced cardiac output in SAH. Because, myocardial cells are already under stress due to increased adrenergic stimulation. The use of exogenous catecholamines may cause additional neurocardiogenic damage in myocardial cells, excessive calcium burden, decreased cerebral blood flow, and delayed cerebral ischemia. By reducing the use of exogenous catecholamines with levosimendan, the vicious circle of cardiotoxicity induced by catecholamines can be broken. Levosimendan is a nonadrenergic inotropic calcium sensitizer that allows rapid recovery of cardiac output and optimizes cerebral perfusion without increasing myocardial oxygen consumption. If we consider that reduction in left ventricular systolic function plays a role in the pathogenesis of delayed cerebral ischemia, the risk of developing neurological complications may be reduced by administration of levosimendan in these patients. Moreover, new evidence from experimental studies also indicates that levosimendan may have neuroprotective effects in the SAH. In this review, the use of levosimendan in the treatment of hemodynamic disorders which develops in the course of SAH has been discussed in company with current literature.
Authors and Affiliations
Tuğçe Mengi, Barış Yılmaz, Ali Necati Gökmen, Uğur Koca
Keywords
Related Articles
- EP ID EP382223
- DOI 10.4274/tybd.05025
- Views 129
- Downloads 0
Clinical Protocols for Preventing Ventilator-Associated Pneumonia: A Systematic Study
Objective: The purpose of this work was to review the current literature evaluating the efficacy of clinical protocols and preservation methods in preventing ventilator-associated pneumonia (VAP), and to examine the data...
Evaluation of Pre-Delirium Score in Intensive Care Patients
Objective: Delirium is frequently seen in intensive care patients and causes prolongation of mechanical ventilation and intensive care stay. In intensive care patients, the pre-delirium score is a test used to detect del...
Spontanous Urinary Bladder Rupture and Urosepsis in Patient with Paraplegia
Spontaneous bladder rupture is a rarely seen clinical condition and usually occurs because of weakening of the bladder wall after urinary retention, urinary tract infections, increased intra-bladder pressure, and alcohol...
Detailed Therapeutic Hypothermia Protocol After Cardiac Arrest
.
Retrospective Evaluation of Four-Year Acute Intoxication Cases Followed-up in Intensive Care Unit
Objective: Acute intoxication is a life-threatining clinical issue. Therefore, patients need follow-up in the intensive care unit (ICU). In this study, we aimed to evaluate the incidence, demographic characteristics, int...